电子病历可以用于减少住院患者DOAC处方错误吗

F. Steffen, C. Mühlen, Armin Nemani, T. Heidt, J. Schulte, C. Bode, M. Krohn-Grimberghe
{"title":"电子病历可以用于减少住院患者DOAC处方错误吗","authors":"F. Steffen, C. Mühlen, Armin Nemani, T. Heidt, J. Schulte, C. Bode, M. Krohn-Grimberghe","doi":"10.35248/2329-6887.21.9.329","DOIUrl":null,"url":null,"abstract":"Background: Direct oral anticoagulants (DOACs) are commonly used for treating or preventing thromboembolic events. At the same time anticoagulants are a notorious cause of medication errors. Such medication errors can jeopardize patients’ health and challenge the economy of healthcare systems. With the potential of e-health systems for reducing medication errors, our study investigates the effects of medication highlighting. Methods: To highlight medications with anticoagulatory properties in the electronic health records of cardiologic inpatients, a color scheme was introduced at our university hospital. We performed chart reviews of DOAC-related medication errors due to co-prescription of more than one anticoagulatory drug or omitted pausing of DOACs before interventions with increased bleeding risks. Chart reviews were performed before and after the introduction of medication highlighting. Patients having received a DOAC prescription at any point in time during their hospital stay were included. Results: 305 (out of 1.045) patients had received DOAC before and 277 (out of 1.062) received DOAC within a three-month period after the color scheme introduction. DOAC-related medication errors occurred in 25 of the 305 (8.2%) inpatients in total before medication highlighting, while 6 errors occurred in 277 inpatients (2.2%; p= 0.0013) afterwards. Conclusion: Highlighting anticoagulatory medications in the electronic medical record led to a reduction of DOACrelated prescription errors.","PeriodicalId":16958,"journal":{"name":"Journal of Pharmacovigilance","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Can Electronic Medical Record be used for Reducing DOAC Prescription Errors in Inpatients\",\"authors\":\"F. Steffen, C. Mühlen, Armin Nemani, T. Heidt, J. Schulte, C. Bode, M. Krohn-Grimberghe\",\"doi\":\"10.35248/2329-6887.21.9.329\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Direct oral anticoagulants (DOACs) are commonly used for treating or preventing thromboembolic events. At the same time anticoagulants are a notorious cause of medication errors. Such medication errors can jeopardize patients’ health and challenge the economy of healthcare systems. With the potential of e-health systems for reducing medication errors, our study investigates the effects of medication highlighting. Methods: To highlight medications with anticoagulatory properties in the electronic health records of cardiologic inpatients, a color scheme was introduced at our university hospital. We performed chart reviews of DOAC-related medication errors due to co-prescription of more than one anticoagulatory drug or omitted pausing of DOACs before interventions with increased bleeding risks. Chart reviews were performed before and after the introduction of medication highlighting. Patients having received a DOAC prescription at any point in time during their hospital stay were included. Results: 305 (out of 1.045) patients had received DOAC before and 277 (out of 1.062) received DOAC within a three-month period after the color scheme introduction. DOAC-related medication errors occurred in 25 of the 305 (8.2%) inpatients in total before medication highlighting, while 6 errors occurred in 277 inpatients (2.2%; p= 0.0013) afterwards. Conclusion: Highlighting anticoagulatory medications in the electronic medical record led to a reduction of DOACrelated prescription errors.\",\"PeriodicalId\":16958,\"journal\":{\"name\":\"Journal of Pharmacovigilance\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacovigilance\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/2329-6887.21.9.329\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacovigilance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2329-6887.21.9.329","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:直接口服抗凝剂(DOACs)通常用于治疗或预防血栓栓塞事件。与此同时,抗凝剂是导致用药错误的一个臭名昭著的原因。此类用药错误可能危及患者的健康,并对医疗保健系统的经济构成挑战。随着电子卫生系统在减少用药错误方面的潜力,我们的研究调查了药物突出的影响。方法:为了在心脏病住院患者的电子病历中突出显示具有抗凝血特性的药物,在我校医院引入了一种配色方案。我们对doac相关的用药错误进行了图表回顾,这些用药错误是由于联合使用一种以上抗凝药物或在干预前遗漏了doac的暂停而导致出血风险增加。在引入药物突出显示之前和之后进行图表回顾。在住院期间的任何时间点接受DOAC处方的患者也包括在内。结果:305例(1.045例)患者之前接受了DOAC治疗,277例(1.062例)患者在配色方案引入后的三个月内接受了DOAC治疗。305例住院患者中有25例(8.2%)在药物突出前发生doac相关用药错误,277例(2.2%)住院患者发生6例用药错误;P = 0.0013)。结论:在电子病历中突出显示抗凝药物可减少与doac相关的处方错误。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Can Electronic Medical Record be used for Reducing DOAC Prescription Errors in Inpatients
Background: Direct oral anticoagulants (DOACs) are commonly used for treating or preventing thromboembolic events. At the same time anticoagulants are a notorious cause of medication errors. Such medication errors can jeopardize patients’ health and challenge the economy of healthcare systems. With the potential of e-health systems for reducing medication errors, our study investigates the effects of medication highlighting. Methods: To highlight medications with anticoagulatory properties in the electronic health records of cardiologic inpatients, a color scheme was introduced at our university hospital. We performed chart reviews of DOAC-related medication errors due to co-prescription of more than one anticoagulatory drug or omitted pausing of DOACs before interventions with increased bleeding risks. Chart reviews were performed before and after the introduction of medication highlighting. Patients having received a DOAC prescription at any point in time during their hospital stay were included. Results: 305 (out of 1.045) patients had received DOAC before and 277 (out of 1.062) received DOAC within a three-month period after the color scheme introduction. DOAC-related medication errors occurred in 25 of the 305 (8.2%) inpatients in total before medication highlighting, while 6 errors occurred in 277 inpatients (2.2%; p= 0.0013) afterwards. Conclusion: Highlighting anticoagulatory medications in the electronic medical record led to a reduction of DOACrelated prescription errors.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信